(0.31%) 5 170.50 points
(0.27%) 38 936 points
(0.25%) 18 045 points
(1.10%) $78.97
(0.56%) $2.15
(0.88%) $2 328.90
(2.60%) $27.39
(0.96%) $974.60
(-0.05%) $0.928
(-0.35%) $10.84
(-0.22%) $0.795
(-0.04%) $91.41
-2.65% $ 0.511
Live Chart Being Loaded With Signals
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation...
Stats | |
---|---|
Dzisiejszy wolumen | 460 710 |
Średni wolumen | 437 269 |
Kapitalizacja rynkowa | 19.42M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0.240 ( 2023-01-13 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0247 |
ATR14 | $0.0370 (7.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Luo Ying | Buy | 3 350 897 | Stock Option (Right to Buy) |
2023-10-30 | Luo Ying | Buy | 2 840 376 | Common Stock |
2023-11-20 | Luo Ying | Buy | 2 262 755 | Stock Option (Right to Buy) |
2023-11-20 | Ye Weiguo | Buy | 1 665 115 | Stock Option (Right to Buy) |
2023-11-20 | Ma Songjiang | Buy | 4 510 047 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
24.88 |
Last 85 transactions |
Buy: 88 748 347 | Sell: 111 334 812 |
Wolumen Korelacja
Catalyst Biosciences Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
CALA | 0.925 |
ODT | 0.917 |
UPC | 0.909 |
BCAB | 0.908 |
NBIX | 0.897 |
LLNW | 0.891 |
ENNV | 0.891 |
LFMD | 0.891 |
YJ | 0.889 |
XPDI | 0.889 |
10 Najbardziej negatywne korelacje | |
---|---|
SHC | -0.922 |
WYNN | -0.921 |
DSPG | -0.917 |
ACLS | -0.913 |
PPD | -0.908 |
BNIX | -0.907 |
DUNE | -0.906 |
RVNC | -0.902 |
HHGC | -0.901 |
FWONK | -0.899 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catalyst Biosciences Inc Korelacja - Waluta/Towar
Catalyst Biosciences Inc Finanse
Annual | 2022 |
Przychody: | $794 000 |
Zysk brutto: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2022 |
Przychody: | $794 000 |
Zysk brutto: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $-7.38M (0.00 %) |
EPS: | $-2.87 |
FY | 2020 |
Przychody: | $20.95M |
Zysk brutto: | $11.79M (56.26 %) |
EPS: | $-2.93 |
Financial Reports:
No articles found.
Catalyst Biosciences Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$1.430 (N/A) |
$0 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $59.77 | 2015-08-20 |
Last Dividend | $0.240 | 2023-01-13 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $61.44 | -- |
Avg. Dividend % Per Year | 39.53% | -- |
Score | 4.37 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.002 | |
Div. Directional Score | 0.464 | -- |
Year | Amount | Yield |
---|---|---|
2015 | $59.77 | 22.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $1.430 | 143.00% |
2023 | $0.240 | 41.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 55.72 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.709 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 12.04 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | -0.289 | -1.000 | -2.89 | 2.89 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -71.39 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.176 | -0.352 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 3.15 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 55.75 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | -0.0127 | 0.800 | -3.42 | -2.73 | [0.5 - 2] |
Total Score | -0.0749 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.439 | 1.000 | -0.145 | 0 | [1 - 100] |
returnOnEquityTTM | 12.04 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.352 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
payoutRatioTTM | -0.289 | 1.500 | -2.89 | 2.89 | [0 - 1] |
pegRatioTTM | -0.00352 | 1.500 | -3.36 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 16.85 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 1.002 |
Catalyst Biosciences Inc
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej